Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses
5 affiliations
- 1Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland
- 2Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 21, 1011 Lausanne, Switzerland
- 3Interdisciplinary Center for Bone Disease, Lausanne University Hospital, 1011 Lausanne, Switzerland
- 4NEXUS Personalized Health, ETH Zurich, 8092 Zurich, Switzerland
- 5Department of Visceral Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland
Abstract
Background/Objectives: Despite recognized physiological limitations, serum prealbumin continues to be measured during nutritional follow-up after bariatric surgery, and low concentrations may be interpreted as indicating inadequate lean-mass preservation. We aimed to evaluate the clinical utility of serum prealbumin for identifying disproportionate DXA-derived lean mass loss during the first three years after Roux-en-Y gastric bypass (RYGB) and to examine its association with DXA-derived lean-mass measurements at long-term follow-up. Methods: In a longitudinal cohort of 178 adults, serum prealbumin and dual-energy X-ray absorptiometry (DXA)-derived body composition were assessed preoperatively, at 6 months, 1 year, and 3 years after surgery. Disproportionate lean mass loss was defined as lean mass accounting for >25% of total body weight lost. A complementary cross-sectional analysis examined associations between prealbumin and body composition in 310 participants assessed at a median of 8.8 years after RYGB. Results: Prealbumin decreased from an estimated 0.260 g/L preoperatively to 0.203 g/L at 6 months and partially recovered thereafter, while absolute lean mass continued to decline through 3 years. Prealbumin showed poor discrimination of disproportionate lean mass loss, with AUCs of 0.36, 0.28, and 0.48 at 6 months, 1 year, and 3 years, respectively, although estimates were imprecise because of the small number of participants meeting the criterion. The <0.20 g/L prealbumin threshold showed low sensitivity of 12–27%. Lower prealbumin concentrations were not significantly associated with the percentage of preoperative lean mass lost at any time point. In the long-term analysis, prealbumin was not meaningfully associated with DXA-derived lean mass measures after adjustment for sex, age, and time since surgery. Conclusions: Serum prealbumin showed limited discriminatory performance for identifying disproportionate DXA-derived lean mass loss during the first three years after RYGB, although estimates were imprecise because of the small number of events. In the long-term cross-sectional cohort, associations with DXA-derived lean-mass measurements were weak. These findings do not support the use of serum prealbumin as a surrogate marker of DXA-derived lean mass preservation after RYGB.
Related
- Assessing theoretical knowledge related to surgical and clinical skills in Syrian medical students : A cross-sectional study.
- Circadian syndrome and incident multisite pain among middle-aged and older Chinese adults: component-specific and longitudinal analyses from CHARLS
- Assessing the robustness of meta-analyses to variability in the frequency and timing of postoperative delirium assessment – a novel methodological approach
- Changes in the frequency of vigorous physical activity across four survey cycles: analyses of 12-year repeated cross-sectional surveys of 729,201 adolescents
- Association of the triglyceride-to-high-density lipoprotein cholesterol ratio with kidney stone status: cross-sectional and machine-learning analyses
BibTeX
@article{santini2026limited,
title = {{Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses}},
author = {Sara Santini and Nathalie Vionnet and Elena Gonzalez-Rodriguez and Jérôme Pasquier and Styliani Mantziari and Lucie Favre},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18213580},
url = {https://www.mdpi.com/2072-6643/18/21/3580},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses
AU - Sara Santini
AU - Nathalie Vionnet
AU - Elena Gonzalez-Rodriguez
AU - Jérôme Pasquier
AU - Styliani Mantziari
AU - Lucie Favre
PY - 2026
DA - 2026/10/29
JO - Nutrients
DO - 10.3390/nu18213580
UR - https://www.mdpi.com/2072-6643/18/21/3580
AB - Background/Objectives: Despite recognized physiological limitations, serum prealbumin continues to be measured during nutritional follow-up after bariatric surgery, and low concentrations may be interpreted as indicating inadequate lean-mass preservation. We aimed to evaluate the clinical utility of serum prealbumin for identifying disproportionate DXA-derived lean mass loss during the first three years after Roux-en-Y gastric bypass (RYGB) and to examine its association with DXA-derived lean-mass measurements at long-term follow-up. Methods: In a longitudinal cohort of 178 adults, serum prealbumin and dual-energy X-ray absorptiometry (DXA)-derived body composition were assessed preoperatively, at 6 months, 1 year, and 3 years after surgery. Disproportionate lean mass loss was defined as lean mass accounting for >25% of total body weight lost. A complementary cross-sectional analysis examined associations between prealbumin and body composition in 310 participants assessed at a median of 8.8 years after RYGB. Results: Prealbumin decreased from an estimated 0.260 g/L preoperatively to 0.203 g/L at 6 months and partially recovered thereafter, while absolute lean mass continued to decline through 3 years. Prealbumin showed poor discrimination of disproportionate lean mass loss, with AUCs of 0.36, 0.28, and 0.48 at 6 months, 1 year, and 3 years, respectively, although estimates were imprecise because of the small number of participants meeting the criterion. The <0.20 g/L prealbumin threshold showed low sensitivity of 12–27%. Lower prealbumin concentrations were not significantly associated with the percentage of preoperative lean mass lost at any time point. In the long-term analysis, prealbumin was not meaningfully associated with DXA-derived lean mass measures after adjustment for sex, age, and time since surgery. Conclusions: Serum prealbumin showed limited discriminatory performance for identifying disproportionate DXA-derived lean mass loss during the first three years after RYGB, although estimates were imprecise because of the small number of events. In the long-term cross-sectional cohort, associations with DXA-derived lean-mass measurements were weak. These findings do not support the use of serum prealbumin as a surrogate marker of DXA-derived lean mass preservation after RYGB.
SN - 2072-6643
ER -